Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
/in Dendritic Cells, Glioblastoma, International PublicationsKiller dendritic cells and their potential for cancer immunotherapy
/in Dendritic Cells, International PublicationsTargeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice
/in Dendritic Cells, International PublicationsCryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy
/in Dendritic Cells, International PublicationsBeyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid CancerVaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
/in Dendritic Cells, International Publications, Malignant Melanoma, Prostate CancerMonocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
/in Dendritic Cells, HIV/AIDS, International PublicationsCellular immunotherapy for ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerPilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer